Utility of partial cure as an end point after nucleos (t)ide analogue withdrawal among chronic hepatitis B patients (RETRACT-B study)

被引：0

作者：

Hirode, Grishma ^{[1
,2
,3
]}

Hansen, Bettina ^{[1
,4
,5
]}

Chen, Chien-Hung ^{[6
]}

Su, Tung-Hung ^{[7
]}

Wong, Grace ^{[8
]}

Seto, Wai-Kay ^{[9
]}

d'Almeida, Arno Furquim ^{[10
]}

Papatheodoridi, Margarita ^{[11
]}

Brakenhoff, Sylvia ^{[12
]}

Lens, Sabela ^{[13
,14
]}

Choi, Hannah S. J.

Van Hees, Stijn

Chien, Rong-Nan ^{[15
]}

Feld, Jordan J. ^{[1
,2
,3
]}

Forns, Xavier ^{[13
,14
]}

Sonneveld, Milan ^{[12
]}

Papatheodoridis, George ^{[11
]}

Vanwolleghem, Thomas ^{[10
]}

Yuen, Man-Fung ^{[9
]}

Chan, Henry L. Y. ^{[8
]}

Kao, Jia-Horng ^{[7
]}

Hsu, Yao-Chun ^{[16
]}

Cornberg, Markus ^{[17
,18
]}

Jeng, Rachel Wen-Juei ^{[15
]}

Janssen, Harry L. A. ^{[1
,12
]}

机构：

[1] Univ Hlth Network, Toronto Gen Hosp, Toronto Ctr Liver Dis, Toronto, ON, Canada

[2] Toronto Viral Hepatitis Care Network VIRCAN, Toronto, ON, Canada

[3] Univ Toronto, Inst Med Sci, Toronto, ON, Canada

[4] Univ Toronto, Inst Hlth Policy Management & Evaluat, Toronto, ON, Canada

[5] Erasmus Univ, Dept Epidemiol, Biostat, Med Ctr, Rotterdam, Netherlands

[6] Kaohsiung Chang Gung Mem Hosp, Dept Gastroenterol & Hepatol, Kaohsiung, Taiwan

[7] Natl Taiwan Univ Hosp, Dept Internal Med, Taipei, Taiwan

[8] Chinese Univ Hong Kong, Med Data Analyt Ctr MDAC, Hong Kong, Peoples R China

[9] Univ Hong Kong, Dept Med & State Key Lab Liver Res, Hong Kong, Peoples R China

[10] Univ Antwerp Hosp, Dept Gastroenterol & Hepatol, Antwerp, Belgium

[11] Natl & Kapodistrian Univ Athens, Dept Gastroenterol, Med Sch, Athens, Greece

[12] Erasmus Univ, Dept Gastroenterol & Hepatol, Med Ctr, Rotterdam, Netherlands

[13] Univ Barcelona, Hosp Clin Barcelona, Liver Unit, IDIBAPS, Barcelona, Spain

[14] Univ Barcelona, CIBEREHD, Barcelona, Spain

[15] Chang Gung Univ, Chang Gung Mem Hosp Linkou Med Ctr, Dept Gastroenterol & Hepatol, Linkou, Taiwan

[16] I Shou Univ, E Da Hosp, Kaohsiung, Taiwan

[17] Hannover Med Sch, Dept Gastroenterol Hepatolol & Endocrinol, Hannover, Germany

[18] Ctr Individualized Infect Med CiiM, Hannover, Germany

来源：

JOURNAL OF HEPATOLOGY | 2023年 / 78卷

关键词：

D O I：

暂无

中图分类号：

R57 [消化系及腹部疾病];

学科分类号：

摘要：

SAT-145

引用

页码：S1132 / S1132

页数：1

共 50 条

[31] Biomarkers for predicting nucleos(t)ide analogs discontinuation and hepatitis B virus recurrence after drug withdrawal in chronic hepatitis B patients
Luo, Mengqi
Zhou, Bin
Hou, Jinlin
Jiang, Deke
HEPATOLOGY RESEARCH, 2022, 52 (04) : 337 - 351
[32] The Baseline and On treatment Predictive Factors of Hepatitis B Relapse after Nucleos(t)ide Analogue Discontinuation in Chronic Hepatitis B: A Prospective study
Kaewdech, Apichat
Sripongpun, Pimsiri
Jundee, Sawangpong
Chamroonkul, Naichaya
Piratvisuth, Teerha
JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, 2019, 34 : 236 - 236
[33] HIGH VIROLOGICAL RELAPSE RATE AFTER NUCLEOS(T)IDE ANALOGUE DISCONTINUATION IN CHRONIC HEPATITIS B
Chi, H.
Arends, P.
Wong, D. K.
Yim, C.
Hansen, B. E.
Janssen, H. L. A.
JOURNAL OF HEPATOLOGY, 2014, 60 (01) : S436 - S436
[34] Tenofovir rescue therapy after multiple nucleos(t)ide analogue treatment failure in chronic hepatitis B patients
Kim, Hyo Jin
Cho, Ju-Yeon
Gwak, Geum-Youn
Paik, Yong-Han
Choi, Moon Seok
Koh, Kwang Cheol
Paik, Seung Woon
Yoo, Byung Chul
Lee, Joon Hyeok
HEPATOLOGY, 2013, 58 : 638A - 638A
[35] Keystone to Secure Safety After Stopping Nucleos(t)ide Analogue Therapy in Chronic Hepatitis B Patients Reply
Hsu, Yao-Chun
Tseng, Cheng-Hao
Nguyen, Mindie H.
CLINICAL GASTROENTEROLOGY AND HEPATOLOGY, 2022, 20 (08) : 1891 - 1892
[36] Effect of Nucleos(t)ide Analogue Therapy on Risk of Intrahepatic Cholangiocarcinoma in Patients With Chronic Hepatitis B
Lee, Teng-Yu
Hsu, Yao-Chun
Yu, Shi-Hang
Lin, Jaw-Town
Wu, Ming-Shiang
Wu, Chun-Ying
CLINICAL GASTROENTEROLOGY AND HEPATOLOGY, 2018, 16 (06) : 947 - +
[37] Withdrawal of Nucleos(t)ide Analogues in the Treatment of Chronic Hepatitis B: A Cornelian Choice
Pol, Stanislas
GASTROENTEROLOGY, 2022, 162 (03) : 698 - 699
[38] Eligibility for Nucleos(t)ide Analogue Treatment Disconti- nuation in Patients with Chronic Hepatitis B
Dias, Joana Gomes
Moradpour, Darius
Mdawar-Bailly, Elise
Fraga, Montserrat
Barbosa, Joana Vieira
SWISS MEDICAL WEEKLY, 2024, 154 : 36S - 37S
[39] NEW NUCLEOS(T)IDE ANALOGUE MONOPROPHYLAXIS AFTER HEPATITIS B IMMUNOGLOBULIN WITHDRAWAL IS SAFE AND EFFECTIVE AGAINST HEPATITIS B RECURRENCE AFTER LIVER TRANSPLANTATION
Cholongitas, E.
Goulis, J.
Antoniadis, N.
Fouzas, I.
Imvrios, G.
Vasiliadis, T.
Papanikolaou, V.
Akriviadis, E.
JOURNAL OF HEPATOLOGY, 2014, 60 (01) : S370 - S371
[40] NUCLEOS(T)IDE ANALOGUE PROPHYLAXIS AFTER HEPATITIS B IMMUNOGLOBULIN WITHDRAWAL IS SAFE AND EFFECTIVE AGAINST HEPATITIS B AND D RECURRENCE AFTER LIVER TRANSPLANTATION
Cholongitas, E.
Vasiliadis, T.
Goulis, I.
Antoniadis, N.
Chalevas, P.
Fouzas, I.
Giakoustidis, D.
Imvrios, G.
Giouleme, O.
Papanikolaou, V.
Akriviadis, E.
JOURNAL OF HEPATOLOGY, 2015, 62 : S322 - S323

← 1 2 3 4 5 →